Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease

Published:2022-11 Issue: Volume:37 Page:12-18
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Willmann Jonas,Vlaskou Badra Eugenia,Adilovic Selma,Christ Sebastian M.,Ahmadsei Maiwand,Mayinger Michael,Guckenberger Matthias,Andratschke Nicolaus

Funder

Gottfried und Julia Bangerter-Rhyner-Stiftung

Schweizerische Akademie der Medizinischen Wissenschaften

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference24 articles.

1. Nonparametric estimation of partial transition probabilities in multiple decrement models;Aalen;Ann Stat,1978

2. Clinical outcomes of stereotactic body radiotherapy with immediate versus delayed hormone therapy in men with oligometastatic recurrence of prostate cancer;Chaw;Clin Oncol,2020

3. De Bleser, Elise, Ruben Willems, Karel Decaestecker, Lieven Annemans, Aurélie De Bruycker, Valérie Fonteyne, Nicolaas Lumen, et al. A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer. Cancers 2020; 12(1). https://doi.org/.

4. Metastasis-directed therapy prolongs efficacy of systemic therapy and improves clinical outcomes in oligoprogressive castration-resistant prostate cancer;Deek;Eur Urol Oncol,2021

5. Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial;Duchesne;Lancet Oncol,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer;Clinical and Translational Radiation Oncology;2024-07

2. REPeated mAgnetic resonance Image-guided stereotactic body Radiotherapy (MRIg-reSBRT) for oligometastatic patients: REPAIR, a mono-institutional retrospective study;Radiation Oncology;2024-04-26

3. Management of Renal Cell Carcinoma With Supradiaphragmatic Inferior Vena Cava Thrombus Diagnosed During Acute COVID-19 Infection;Cureus;2024-03-05

4. Stereotactic body radiation therapy for bone oligometastases;Cancer/Radiothérapie;2024-02

5. Stereotactic radiotherapy in the management of oligometastatic and recurrent head and neck cancer: a single-center experience;Strahlentherapie und Onkologie;2023-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3